U.S.-Listed ETF listed on a U.S. stock exchange

The ETF: HealthShares Metabolic-Endocrine Disorders ETF (HHM)

All ETFs  >  Stock ETFs  >  By Industry  >  Health Care
All ETFs  >  Stock ETFs  >  By Region  >  US ETFs

HealthShares Metabolic-Endocrine Disorders ETF
HHM seeks to provide investment results generally equivalent to the performance of HealthShares Metabolic-Endocrine Disorders Index, an equity index of publicly traded common stocks and ADRs. The Metabolic-Endocrine Disorders Index invests in healthcare, life sciences and/or biotechnology companies that have been identified as metabolic-endocrine disorders companies. Companies included in the Metabolic-Endocrine Disorders Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of metabolic-endocrine disorders including, but not limited to, diabetes, obesity, Syndrome X, growth deficiency and rare lysosomal disorders.

Investment type: ETF (Exchange-Traded Fund); listed on the U.S. NYSE exchange
Ticker symbol: HHM

Fund manager: HealthShares

Fund information from HealthShares: HealthShares Metabolic-Endocrine Disorders ETF

This ETF has been discontinued


• Information on this website should not be considered to be investment advice. Any ETF can go DOWN as well as up.
• Information on this website should not be assumed to be complete or correct. Funds can also change their investment goals. That's why, wherever possible, we provide links to the actual fund sponsor and the exchange on which the fund trades.
Created by Specifica, Inc.: Original content and unique compilation of information are copyright 2010.